Stock 300676 BGI GENOMICS CO., LTD.
Add to a list
To use this feature you must be a member
Log inSign up

BGI Genomics Co., Ltd. Share Price

Equities

300676

CNE100003449

Biotechnology & Medical Research

End-of-day quote Shenzhen S.E.
Other stock markets
 03:30:00 31/05/2024 am IST 		5-day change 1st Jan Change
39.26 CNY +0.62% Intraday chart for BGI Genomics Co., Ltd. +0.15% -18.21%
20/05 US Legislation Banning Chinese Biotech Firms Will Suppress Legislation, BGI Says MT
10/05 Bgi Genomics Co., Ltd. Approves Cash Dividend for 2023 CI

Financials

Sales 2022 704.61Cr 97Cr 8.12TCr Sales 2023 434.96Cr 60Cr 5.01TCr Capitalization 1.97TCr 271.73Cr 23TCr
Net income 2022 80Cr 11Cr 925.01Cr Net income 2023 9.2Cr 1.27Cr 105.98Cr EV / Sales 2022 2.13 x
Net cash position 2022 620.93Cr 86Cr 7.15TCr Net cash position 2023 512.06Cr 71Cr 5.9TCr EV / Sales 2023 3.35 x
P/E ratio 2022
26.4 x
P/E ratio 2023
213 x
Employees -
Yield 2022
1.93%
Yield 2023
0.21%
Free-Float 52.17%
More Fundamentals * Assessed data

Chart BGI Genomics Co., Ltd.

Dynamic Chart

Latest news about BGI Genomics Co., Ltd.

US Legislation Banning Chinese Biotech Firms Will Suppress Legislation, BGI Says MT
Bgi Genomics Co., Ltd. Approves Cash Dividend for 2023 CI
BGI Genomics Co., Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2024 CI
BGI Genomics Co., Ltd. Proposes Final Cash Dividend for the Year 2023 CI
BGI Genomics' 2023 Profit Falls 89% as Revenue Plunges 38% MT
BGI Genomics Co., Ltd. Reports Earnings Results for the Full Year Ended December 31, 2023 CI
China stocks rise further on market rescue hopes; HK flat RE
Wuxi AppTec Denies Ties to Military in Wake of US Draft Bill Targeting Chinese Biotech Firms MT
US bill targeting Chinese biotech firms WuXi AppTec, BGI hits delay RE
Correction: GemPharmatech Responds to US Legislation Concerns MT
Correction: Chinese Shares End Lower on US Draft Bill Targeting Chinese Biotech Firms; MGI Slumps 12%, Wuxi AppTec Falls 9% MT
GemPharmatech Responds to US Legislation Concerns MT
MGI Tech Responds to US BIOSECURE Act MT
Chinese Shares End Lower on US Draft Bill Targeting Chinese Biotech Firms; MGI Slumps 12%, Wuxi AppTec Falls 9% MT
US House bill would curb genetic info sharing with China's Wuxi Apptec, BGI RE
More news

Press releases BGI Genomics Co., Ltd.

BGI-HL OHA Lab inaugurated in Harbin, initiating colorectal cancer risk assessment for 800,000 AQ
Navigating The Pending BIOSECURE Act: Implications For U.S.-China Biopharmaceutical Collaboration And National Security AQ
China US Technology Curbs AQ
New World Development Company Limited - Share for Good Receives Support from All Corners of Hong Kong, Cafe de Coral Donates 500,000 Dining Vouchers to 17 NGOs AQ
BGI Genomics : Ethiopian Launches High - End Covid-19 Testing Lab AQ
More press releases

News in other languages on BGI Genomics Co., Ltd.

EEUU denuncia a las empresas chinas que ayudan al ejército de Pekín
Illumina tendrá que desprenderse de Grail después que la UE bloquee su adquisición
PRESSESPIEGEL/Unternehmen
BGI Genomics : Chinesische Firma sammelt weltweit Gendaten von Schwangeren
Coronavirus: le point sur la pandémie
More news

Quotes and Performance

1 day+0.62%
1 week+0.15%
1 month-4.55%
3 months-11.22%
6 months-24.03%
Current year-18.21%
More quotes

Highs and lows

1 week
38.69
Extreme 38.69
39.74
1 month
38.69
Extreme 38.69
44.36
Current year
33.00
Extreme 33
48.30
1 year
33.00
Extreme 33
62.97
3 years
33.00
Extreme 33
130.26
5 years
33.00
Extreme 33
199.40
10 years
16.37
Extreme 16.37
261.99
More quotes

Managers and Directors - BGI Genomics Co., Ltd.

Managers TitleAgeSince
Li Jian Zhao CEO
 Chief Executive Officer - 16/21/16
Jian Hua Wang FOU
 Founder 70 -
Yu Jue Wang DFI
 Director of Finance/CFO 46 16/21/16
Members of the board TitleAgeSince
Jian Hua Wang FOU
 Founder 70 -
Hong Tao Wang BRD
 Director/Board Member - 29/16/29
Ye Yin BRD
 Director/Board Member 45 -
More insiders

Quotes

Date Price Change Volume
31/24/31 39.26 +0.62% 2,016,377
30/24/30 39.02 +0.13% 1,778,155
29/24/29 38.97 -0.13% 1,692,127
28/24/28 39.02 -1.17% 1,617,400
27/24/27 39.48 +0.71% 2,071,700

End-of-day quote Shenzhen S.E., May 31, 2024

More quotes

Company Profile

BGI Genomics Co., Ltd. is a leading provider of genomic and proteomic sequencing services primarily to academic institutions, pharmaceutical companies and healthcare providers. The company also provides genomic solutions for biomarker research and development, screening for some of the trisomies present at birth (trisomy 21, trisomy 18 and trisomy 13) and solutions for neo-antigen identification for immuno-oncology research.
Sector
Biotechnology & Medical Research
Calendar
29/08/2024 - Q2 2024 Earnings Release (Projected)
More about the company

Income Statement Evolution

More financial data

Annual profits - Rate of surprise

Company calendar

Sector Bio Diagnostics & Testing

1st Jan change Capi.
BGI GENOMICS CO., LTD. Stock BGI Genomics Co., Ltd.
-18.21% 205.7Cr
EXACT SCIENCES CORPORATION Stock Exact Sciences Corporation
-38.56% 838.69Cr
GUARDANT HEALTH, INC. Stock Guardant Health, Inc.
+0.18% 331.62Cr
IOVANCE BIOTHERAPEUTICS, INC. Stock Iovance Biotherapeutics, Inc.
+9.29% 248.49Cr
VERACYTE, INC. Stock Veracyte, Inc.
-24.57% 158.63Cr
MARAVAI LIFESCIENCES HOLDINGS, INC. Stock Maravai LifeSciences Holdings, Inc.
+32.37% 115.16Cr
SEEGENE, INC. Stock Seegene, Inc.
-7.64% 70Cr
CAREDX, INC Stock CareDx, Inc
+8.42% 68Cr
ADAPTIVE BIOTECHNOLOGIES CORPORATION Stock Adaptive Biotechnologies Corporation
-29.59% 51Cr
CURIOX BIOSYSTEMS CO., LTD Stock Curiox Biosystems Co., Ltd
-6.56% 27Cr
Bio Diagnostics & Testing
  1. Stock Market
  2. Equities
  3. 300676 Stock